§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US5087623A Expired / Lapsed US ⏱️ 0.0 years remaining

Chromic picolinate treatment

Assignee: Nutrition 21 LLC
•
Filing: 1989-03-21
•
Granted: 1992-02-11
•
Expires: 2009-03-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the adminstration is for controlling desirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is admistered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.

Inventors

  • 👤 Herb Boynton
  • 👤 Gary W. Evans

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 15:41
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/555

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 34 words
A method for reducing hyperglycemia and stabilizing the level of serum glucose in humans comprising the administration of an effective amount of a composition comprising synthetic chromic tripicolinate to a human in need thereof.
Claim 2
Independent Claim 34 words
A method for reducing hyperglycemia and stabilizing the level of serum glucose in humans comprising the administration of an effective amount of a composition comprising synthetic chromic tripicolinate to a human in need thereof.
Claim 3
Dependent Claim 19 words
The method of claim 1 wherein said chromic tripicolinate is in a pharmaceutically acceptable carrier and is orally ingested.
Claim 4
Dependent Claim 27 words
The method of claim 1 wherein said chromic tripicolinate is present in a pharmaceutically acceptable carrier in a dose having at least about 50 micrograms of chromium.
Claim 5
Dependent Claim 29 words
The method of claim 1 wherein said chromic tripicolinate is present in a pharmaceutically acceptable carrier in a dose having from about 50 to about 500 micrograms of chromium.
Claim 6
Dependent Claim 23 words
The method of claim 1, wherein about 200 micrograms chromium as of chromic tripicolinate are administered each day for a plurality of days.
Claim 7
Dependent Claim 24 words
The method of claim 1, wherein about 200 micrograms chromium as of chromic tripicolinate are administered each day for at least about 40 days.
Claim 8
Independent Claim 48 words
A method for reducing hyperglycemia and for stabilizing the level of serum glucose in an individual, comprising administering chromic picolinate, which is substantially free of impurities from brewer's yeast, in an effective dose having at least 50 micrograms of chromium per day to an individual in need thereof.
Claim 9
Independent Claim 48 words
A method for reducing hyperglycemia and for stabilizing the level of serum glucose in an individual, comprising administering chromic picolinate, which is substantially free of impurities from brewer's yeast, in an effective dose having at least 50 micrograms of chromium per day to an individual in need thereof.
Claim 10
Dependent Claim 19 words
The method of claim 7 wherein said chromic tripicolinate is in a pharmaceutically acceptable carrier and is orally ingested.

References Cited (Backward Citations)

US2974043A Cited
US4343905A Cited
US4315927A Cited
US4923855A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-02-10 1995-08-12 1996-02-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-02-10 1999-08-12 2000-02-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-02-10 2003-08-12 2004-02-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag